grekovВестник хирургии имени И.И. ГрековаGrekov's Bulletin of Surgery0042-46252686-7370Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russia10.24884/0042-4625-2024-183-6-64-70grekov-2542Research ArticleОБЗОРЫREVIEWSВнутрисосудистое лечение острого ишемического инсультаCurrent endovascular treatment of acute ischemic strokehttps://orcid.org/0000-0002-9715-5505КандыбаД. В.KandybaD. V.

Кандыба Дмитрий Вячеславович, кандидат медицинских наук, главный врач; ассистент кафедры нейрохирургии

192242, Санкт-Петербург, Будапештская ул., д. 3, лит. А; 194044, Санкт-Петербург, ул. Академика Лебедева, д. 6

Kandyba Dmitriy V., Cand. of Sci. (Med.), Chief Physician;Assistant of the Department of Neurosurgery

3, Budapeshtskaya str., Saint Petersburg, 192242;6, Academica Lebedeva str., Saint Petersburg, 194044

kandybadv@me.comhttps://orcid.org/0000-0002-4797-2937БабичевК. Н.BabichevK. V.

Бабичев Константин Николаевич, младший научный сотрудник, врач; нейрохирург, клиника нейрохирургии

192242, Санкт-Петербург, Будапештская ул., д. 3, лит. А; 194044, Санкт-Петербург, ул. Академика Лебедева, д. 6

Babichev Konstantin N., Junior Research Fellow, Doctor; Neurosurgeon, Neurosurgery Clinic

3, Budapeshtskaya str., Saint Petersburg, 192242;6, Academica Lebedeva str., Saint Petersburg, 194044

k_babichev@mail.ruСанкт-Петербургский научно-исследовательский институт скорой помощи им. И. И. Джанелидзе; Военно-медицинская академия имени С. М. КироваРоссияSaint-Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine; Military Medical AcademyRussian Federation20243001202518366470Copyright © Кандыба Д.В., Бабичев К.Н., 20252025Кандыба Д.В., Бабичев К.Н.Kandyba D.V., Babichev K.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vestnik-grekova.ru/jour/article/view/2542

Острый ишемический инсульт является одной из ведущих причин смерти и длительной нетрудоспособности. Долгое время внутривенный тромболизис рекомбинантным активатором плазминогена тканевого типа (rt-PA) был единственным методом лечения пациентов с острым ишемическим инсультом. Однако в настоящее время внутрисосудистые методы лечения позволяют достичь значительно более высоких показателей реканализации и хорошего функционального исхода по сравнению с внутривенной rt-PA у пациентов с ишемическим инсультом вследствие окклюзии крупных церебральных сосудов. В этой статье представлена информация и обсуждается роль внутрисосудистых методов в лечении острого ишемического инсульта.

Acute ischemic stroke is one of the leading causes of death and long-term disability. For a long time, intravenous thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) has been the only method of treating patients with acute ischemic stroke. However, at present, endovascular treatment allows to achieve better revascularization and good functional outcomes compared with intravenous rt-PA in patients with ischemic stroke due to large vessel occlusion. This article provides an update and discusses the role of endovascular therapy in management of acute ischemic stroke.

внутрисосудистое лечениеишемический инсульттромбэктомияendovascular treatmentischemic strokethrombectomyнетReferencesBenjamin E. J., Muntner P., Alonso A. et al. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019. Vol. 139, № 10. P. e56–e528.Benjamin E. J., Muntner P., Alonso A. et al. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56–e528.Roth G. A., Forouzanfar M. H., Moran A. E. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015. Vol. 372, № 14. P. 1333–41. https://doi.org/10.1056/nejmoa1406656.Roth G. A., Forouzanfar M. H., Moran A. E. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–41. https://doi.org/10.1056/nejmoa1406656.Zeumer H., Hacke W., Ringelstein E. B. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983. Vol. 4, № 3. P. 401–404. PMID: 641075.Zeumer H., Hacke W., Ringelstein E. B. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983;4(3):401–404. PMID: 641075.Alexandrov A. V., Molina C. A., Grotta J. C. et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004. Vol. 351. P. 2170–2178. https://doi.org/10.1056/NEJMoa041175.Alexandrov A. V., Molina C. A., Grotta J. C. et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004; 351:2170–2178. https://doi.org/10.1056/NEJMoa041175.Furlan A., Higashida R., Wechsler L. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999. Vol. 282, № 21. P. 2003–11.Furlan A., Higashida R., Wechsler L. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282(21):2003–11.Ишемический инсульт и транзиторная ишемическая атака у взрослых. Клинические рекомендации. 2021 г.Ischemic stroke and transient ischemic attack in adults. Clinical recommendations. 2021 г. (In russ.).Jovin T. G., Chamorro A., Cobo E. et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015. Vol. 372. P. 2296–2306.Jovin T. G., Chamorro A., Cobo E. et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306.Saver J. L., Goyal M., Bonafe A. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015. Vol. 372. P. 2285–2295.Saver J. L., Goyal M., Bonafe A. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372:2285–2295.Goyal M., Demchuk A. M., Menon B. K. et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015. Vol. 372. P. 1019–1030.Goyal M., Demchuk A. M., Menon B. K. et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030.Berkhemer O. A., Fransen P. S., Beumer D. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015. Vol. 372. P. 11–20.Berkhemer O. A., Fransen P. S., Beumer D. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015. Vol. 46. P. 000-000.2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:000-000.Nogueira R. G., Jadhav A. P., Haussen D. C. et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018. Vol. 378, № 1. P. 11–21. https://doi.org/10.1056/NEJMoa1706442.Nogueira R. G., Jadhav A. P., Haussen D. C. et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11–21. https://doi.org/10.1056/NEJMoa1706442.Albers G. W., Marks M. P., Kemp S. et al. Thrombectomy for stroke with perfusion imaging selection at 6–16 hours. N Engl J Med. 2018. Vol. 378. P. 708–18. https://doi.org/10.1056/NEJMoa1713973.Albers G. W., Marks M. P., Kemp S. et al. Thrombectomy for stroke with perfusion imaging selection at 6–16 hours. N Engl J Med. 2018;378:708– 18. https://doi.org/10.1056/NEJMoa1713973.Campbell B. C., Mitchell P. J., Kleinig T. J. et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015. Vol. 372. P. 1009–1018.Campbell B. C., Mitchell P. J., Kleinig T. J. et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–1018.Schonewille W. J., Wijman C. A. C., Michel P. et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009. Vol. 8. P. 724–730. https://doi.org/10.1016/S1474-4422(09)70173-5.Schonewille W. J., Wijman C. A. C., Michel P. et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724–730. https://doi.org/10.1016/S1474-4422(09)70173-5.Liu X., Dai Q., Ye R. et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020. Vol. 19. P. 115–122. https://doi.org/10.1016/S1474-4422(19)30395-3.Liu X., Dai Q., Ye R. et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020;19:115–122. https://doi.org/10.1016/S1474-4422(19)30395-3.Tao C., Nogueira R. G., Zhu Y. et al. Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion. N Engl J Med. 2022. Vol. 387, № 15. P. 1361–1372. https://doi.org/10.1056/NEJMoa2206317.Tao C., Nogueira R. G., Zhu Y. et al. Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion. N Engl J Med. 2022;387(15):1361–1372. https://doi.org/10.1056/NEJMoa2206317.Jovin T. G., Li C., Wu L. et al. Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2022. Vol. 387, № 15. P. 1373–1384. https://doi.org/10.1056/NEJMoa2207576.Jovin T. G., Li C., Wu L. et al. Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2022; 387(15):1373–1384. https://doi.org/10.1056/NEJMoa2207576.Langezaal L. C. M., van der Hoeven E. J. R. J., Mont’Alverne F. J. A. et al. Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2021. Vol. 384, № 20. P. 1910–1920. https://doi.org/10.1056/NEJMoa2030297.Langezaal L. C. M., van der Hoeven E. J. R. J., Mont’Alverne F. J. A. et al. Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2021;384(20):1910–1920. https://doi.org/10.1056/NEJMoa2030297.

The authors declare that there are no conflicts of interest present.